Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · IEX Real-Time Price · USD
0.525
-0.021 (-3.83%)
At close: Jul 19, 2024, 4:00 PM
0.524
-0.001 (-0.21%)
Pre-market: Jul 22, 2024, 6:38 AM EDT
Spruce Biosciences Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Spruce Biosciences stock have an average target of 2.50, with a low estimate of 2.00 and a high estimate of 3.00. The average target predicts an increase of 376.10% from the current stock price of 0.53.
Analyst Consensus: Hold
* Price targets were last updated on Jun 13, 2024.
Analyst Ratings
The average analyst rating for SPRB stock from 7 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 0 | 0 | 0 | 0 | 0 |
Buy | 5 | 3 | 3 | 3 | 2 | 2 |
Hold | 0 | 5 | 5 | 5 | 5 | 5 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 7 | 8 | 8 | 8 | 7 | 7 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Oppenheimer | Oppenheimer | Buy Maintains $4 → $3 | Buy | Maintains | $4 → $3 | +471.32% | Jun 13, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jun 5, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 14, 2024 |
RBC Capital | RBC Capital | Buy → Hold Downgrades $9 → $2 | Buy → Hold | Downgrades | $9 → $2 | +280.88% | Mar 14, 2024 |
JMP Securities | JMP Securities | Buy Maintains $8 → $3 | Buy | Maintains | $8 → $3 | +471.32% | Mar 14, 2024 |
Financial Forecast
Revenue This Year
6.39M
from 10.09M
Decreased by -36.65%
Revenue Next Year
2.60M
from 6.39M
Decreased by -59.30%
EPS This Year
-1.26
from -1.24
EPS Next Year
-1.07
from -1.26
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 11.2M | 5.5M | 12.1M | 17.3M | 75.3M |
Avg | 6.4M | 2.6M | 5.6M | 5.5M | 36.0M |
Low | 2.0M | n/a | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 10.6% | -14.6% | 364.2% | 208.8% | 1,274.2% |
Avg | -36.7% | -59.3% | 115.7% | -2.3% | 555.8% |
Low | -80.6% | - | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -1.23 | -0.67 | -0.46 | -0.67 | -0.38 |
Avg | -1.26 | -1.07 | -1.05 | -0.97 | -0.64 |
Low | -1.30 | -1.39 | -1.57 | -1.78 | -0.81 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.